# Help

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/help-3

- Industry: Biotechnology
- Headquarters: Nanjing, China
- Website: www.helpsci.com.cn
- Total disclosed funding: $7.5M
- Latest round: Series D (Dec 3, 2025)
- Investors on record: 10

## About

Based in Nanjing, China and founded in 2016, Nanjing Aierpu Regenerative Medicine Technology Co., Ltd., trading as Help, is a biology technology company which applies iPSC induced pluripotent stem cell technology for the regeneration application of cardiac muscle, liver, nerve, other organs. In November 2025, Help raised a series D funding from new investor Sinowisdom and returning investors Share Capital and Jolmo Capital.
The company has built a iPSC bank with hundreds of iPSC lines derived from healthy donors and rare disease patient. It is responsible for IPSC oriented research, including cell therapy, disease modeling, drug screening and safety evaluation. It also established induced pluripotent stem cell (iPSC) product manufacturing system.

## Funding rounds

- Series D, Dec 3, 2025 — Sinowisdom, Share Capital, Jolmo Capital
- Series C, Nov 15, 2021 — Bison Capital Asset Management, Share Capital, Purple Cow Startups, Jolmo Capital, Ming Bioventures
- Series A, Oct 15, 2020, $7.5M — Legend Star, Purple Cow Startups, Dynamic Capital, Nanjing Gaoke
- Series A, May 5, 2019 — Purple Cow Startups, Lead Wealth Capital, Nanjing Gaoke
- Angel, Aug 3, 2017 — Legend Star

## Investors

- Legend Star (https://capitalatlas.ai/funds/legend-star) — Angel, Series A
- Purple Cow Startups (https://capitalatlas.ai/funds/purple-cow-startups) — Series A, Series C
- Lead Wealth Capital (https://capitalatlas.ai/funds/lead-wealth-capital) — Series A
- Nanjing Gaoke — Series A
- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Series A
- Bison Capital Asset Management (https://capitalatlas.ai/funds/bison-capital-asset-management) — Series C
- Share Capital (https://capitalatlas.ai/funds/share-capital) — Series C, Series D
- Jolmo Capital (https://capitalatlas.ai/funds/jolmo-capital) — Series C, Series D
- Ming Bioventures (https://capitalatlas.ai/funds/ming-bioventures) — Series C
- Sinowisdom (https://capitalatlas.ai/funds/sinowisdom) — Series D